Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy ; volume:6 ; number:3 ; year:2020 ; pages:168-180
Kidney diseases ; 6, Heft 3 (2020), 168-180

Urheber
Yamada, Koshi
Huang, Zhi qiang
Raska, Milan
Reily, Colin
Anderson, Joshua C.
Suzuki, Hitoshi
Kiryluk, Krzysztof
Gharavi, Ali G.
Julian, Bruce A.
Willey, Christopher D.
Novak, Jan

DOI
10.1159/000505748
URN
urn:nbn:de:101:1-2020060400005765532302
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:53 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Yamada, Koshi
  • Huang, Zhi qiang
  • Raska, Milan
  • Reily, Colin
  • Anderson, Joshua C.
  • Suzuki, Hitoshi
  • Kiryluk, Krzysztof
  • Gharavi, Ali G.
  • Julian, Bruce A.
  • Willey, Christopher D.
  • Novak, Jan

Ähnliche Objekte (12)

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1

Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy

Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis

Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis

Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression

Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression

Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy

Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy

Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy

Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy

IgA nephropathy today : 10 tables

Konferenzschrift | Kongress

IgA nephropathy today : 10 tables

Current treatment of IgA nephropathy

Current treatment of IgA nephropathy

Complement activation in IgA nephropathy

Complement activation in IgA nephropathy

IgA Nephropathy: A Chinese Perspective

IgA Nephropathy: A Chinese Perspective

Verbundene Objekte